Loading...

LXRX LEXICON PHARMACEUTICALS INC Capital Structure Changes 8-K Filing

LXCN

LXRX

LEXICON PHARMACEUTICALS INC

(LXRX)

2025 8-K

Stock Sale Agreement

Stock Sale Agreement

Financial Results Report

Financial Statements

Equity Offerings

Financial Statements

Earnings Report

Earnings Report

Earnings Report

Earnings Report

Earnings Report

Earnings Report

Earnings Report

Filing with Quantitative Data

Filing with Quantitative Data

Filing with Quantitative Data

Capital Structure Change

Private Placement

Contract Renewal

Quantitative Data

External Links:

Lexicon Pharmaceuticals, Inc. reported on November 6, 2025, that it has filed a prospectus to sell up to $75 million in common stock through Jefferies LLC under an existing sales agreement, though no sales have occurred yet.

AI Assistant

LEXICON PHARMACEUTICALS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.